Zepbound cost in 2026: list price, self-pay, and the $25 copay

Zepbound costs $299 to $449 a month as of October 2026 if you pay cash through Lilly’s self-pay program (vial or KwikPen, by dose, refilling within 45 days), as little as $25 with commercial insurance that covers it, and $50 a month for eligible Medicare patients through the GLP-1 Bridge. Its list price is about $1,086.

“How much does Zepbound cost?” has no single answer, because Zepbound has at least three prices depending on how you get it. The headline number you see in the news — over a thousand dollars a month — is a list price almost no one actually pays. What you pay depends on your insurance, Lilly’s direct programs, and whether you qualify for a savings card. Here is the current map, with figures checked against Lilly’s own pages in October 2026. For how GLP-1 pricing works in general, see our explainer on GLP-1 cost and insurance coverage.

What is Zepbound’s list price, and what do people actually pay?

Zepbound’s monthly list price for the single-dose pens is approximately $1,086for a 28-day supply.^[1] But list price is a sticker, not a bill. Almost everyone pays through one of two doors instead: their insurance (if it covers Zepbound), or Lilly’s own self-pay program for those without coverage. Which door you walk through changes the number by an order of magnitude.

How much does Zepbound cost without insurance?

For people paying out of pocket, Lilly sells Zepbound directly through LillyDirect in two self-pay formats: single-dose vials (four per month, syringes bought separately) and the single-patient-use KwikPen, a multi-dose pen that holds a month of weekly doses. Both are priced the same by dose, as a 4-week supply: $299/month for 2.5 mg, $399 for 5 mg, and $449 for 7.5 mg and above(as of October 2026).^[7] There is a catch worth flagging: the $449 price for the higher doses depends on refilling within 45 days of your previous delivery (Lilly calls this the Zepbound Journey Program). Miss that window and the regular self-pay price applies: $499 for 7.5 mg and $699 for 10 mg, 12.5 mg and 15 mg.^[7] The 2.5 mg dose is a starter strength, not a maintenance dose, so most people settle at the $449 tier.

How do I get Zepbound for $25 a month?

If you have commercial insurance that covers Zepbound, the manufacturer savings card can bring your copay down to as little as $25 for a 1-, 2-, or 3-month fill.^[2]The fine print matters: savings are capped at $100 per month (up to $300 for a 3-month fill), with a separate annual maximum of $1,300, and a limit of 13 fills per calendar year; the current card expires December 31, 2026.^[2] If your commercial plan does not cover Zepbound, the card brings the single-dose pen to as low as $499 a month, or you can use the KwikPen at the $299–$449 self-pay prices.^[2]

Is compounded tirzepatide still a legal way to save?

During the 2023–24 shortage, compounded tirzepatide was a cheap workaround. That door has largely closed. The FDA declared the tirzepatide shortage resolved in October 2024, which ended the broad compounding exceptions. In February 2026 the FDA announced it intends to restrict GLP-1 ingredients meant for mass-marketed, non-approved compounded copies,^[6] and on April 30, 2026 it went further, proposing to exclude tirzepatide (along with semaglutide and liraglutide) from the list of bulk substances outsourcing facilities may compound.^[3] The practical takeaway: a cheap “compounded tirzepatide” offer in 2026 is operating in a shrinking and legally contested space, not a settled discount channel.

Why the price is a clinical issue, not just a budgeting one

Cost is not separate from whether the drug works, because tirzepatide only keeps working while you keep taking it. Real-world studies of why people stop GLP-1 and dual-agonist therapy find that cost and loss of coverage are among the leading reasons for discontinuation, alongside side effects.^[4] Since stopping typically reverses much of the weight loss, an affordability gap is effectively a treatment failure. The cheapest plan that you can sustain usually beats a slightly cheaper one you can’t.

The honest bottom line

If you have commercial insurance that covers Zepbound, the savings card likely puts you near $25 a month. If you’re paying cash, Lilly’s self-pay vials run $299–$449 depending on dose, provided you refill on schedule. If you’re on Medicare, the savings card doesn’t apply, but the Medicare GLP-1 Bridge caps the cost at $50 a month for eligible patients through 2027; on Medicaid, coverage depends on your state plan. Compounded tirzepatide is no longer a reliable or clearly legal discount. Prices in this market change often, so verify the current figure on Lilly’s site before you budget. For how the actual results compare with Wegovy — and whether the price gap is worth it — see Zepbound vs Wegovy, and our guide to GLP-1 providers for the routes to a prescription.